Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan

被引：0
|
作者：
Motoshi Hattori
Akira Matsunaga
Yuko Akioka
Shuichiro Fujinaga
Takuhito Nagai
Osamu Uemura
Hyogo Nakakura
Akira Ashida
Koichi Kamei
Shuichi Ito
Takuji Yamada
Yoshimitsu Goto
Toshiyuki Ohta
Masataka Hisano
Yasuhiro Komatsu
Noritomo Itami
机构：
[1] Tokyo Women’s Medical University,Department of Pediatric Nephrology, School of Medicine
[2] Yamagata City Hospital Saiseikan,Department of Pediatrics
[3] Saitama Children’s Medical Center,Division of Nephrology
[4] Aichi Children’s Health and Medical Center,Department of Pediatric Nephrology
[5] Osaka Medical Collage,Department of Pediatrics
[6] National Center for Child Health and Development,Division of Nephrology and Rheumatology
[7] Nagoya Daini Red Cross Hospital,Department of Pediatrics
[8] Hiroshima Prefectural Hospital,Department of Pediatric Nephrology
[9] Chiba Children’s Hospital,Department of Nephrology
[10] St. Luke’s International Hospital,Division of Nephrology, Department of Medicine
[11] Nikko Memorial Hospital,Kidney Center
来源：
Clinical and Experimental Nephrology | 2013年 / 17卷
关键词：
Anemia; Children; Peritoneal dialysis; Darbepoetin alfa;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：582 / 588
页数：6
相关论文
共 50 条
  • [41] Anemia treatment patterns in chronic kidney disease in pre-dialysis patients using darbepoetin alfa (NESP)
    Lunde, Martin
    Fahrbach, Kyle
    Nalysnyk, Luba
    del Aguila, Michael
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (04) : A57 - A57
  • [42] Thromboembolic Events with Vadadustat vs. Darbepoetin Alfa for Anemia Treatment in Patients with Dialysis-Dependent CKD
    Parfrey, Patrick S.
    Luo, Wenli
    Maroni, Brad
    Anders, Robert
    Vargo, Dennis
    McCullough, Peter A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 184 - 184
  • [43] Prospective study of inflammatory biomarkers in patients undergoing peritoneal dialysis
    Rios, D. R. A.
    Velloso, M. S. S.
    Lima, S. M. A.
    Turani, S. A. D.
    Rodrigues, L. S. M.
    Pinheiro, M. B.
    Dusse, L. M. S.
    Sabino, A. P.
    Gomes, K. B.
    Pinto, S. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 1107 - 1107
  • [44] A prospective study of transperitoneal transport in patients undergoing peritoneal dialysis
    Graff, J
    Fugleberg, S
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1997, 31 (05): : 469 - 475
  • [45] Population pharmacokinetics of darbepoetin alfa in haemodialysis and peritoneal dialysis patients after intravenous administration
    Takama, Hirotaka
    Tanaka, Hideji
    Nakashima, Daisuke
    Ogata, Hiroyasu
    Uchida, Eiji
    Akizawa, Tadao
    Koshikawa, Shozo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (03) : 300 - 309
  • [46] TREATMENT OF DIALYSIS ANEMIA WITH ERYTHROPOIETIN - A SPANISH MULTICENTER STUDY
    MARINE, M
    NEFROLOGIA, 1990, 10 : 59 - 70
  • [47] Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study
    Franz Schaefer
    Bernd Hoppe
    Therese Jungraithmayr
    Günter Klaus
    Lars Pape
    Mourad Farouk
    Janet Addison
    Nick Manamley
    Karel Vondrak
    Pediatric Nephrology, 2016, 31 : 443 - 453
  • [48] Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study
    Schaefer, Franz
    Hoppe, Bernd
    Jungraithmayr, Therese
    Klaus, Guenter
    Pape, Lars
    Farouk, Mourad
    Addison, Janet
    Manamley, Nick
    Vondrak, Karel
    PEDIATRIC NEPHROLOGY, 2016, 31 (03) : 443 - 453
  • [49] Encapsulating peritoneal sclerosis in Japan: Prospective multicenter controlled study
    Kawanishi, H
    PERITONEAL DIALYSIS INTERNATIONAL, 2001, 21 : S67 - S71
  • [50] Encapsulating peritoneal sclerosis in Japan: A prospective, controlled, multicenter study
    Kawanishi, H
    Kawaguchi, Y
    Fukui, H
    Hara, S
    Imada, A
    Kubo, H
    Kin, M
    Nakamoto, M
    Ohira, S
    Shoji, T
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (04) : 729 - 737
12345